Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
NANautilus Biotechnolgy, Inc. logo

Nautilus Biotechnolgy, Inc. (NAUT)

NASDAQ Capital Market · Currency in USD
$3.24 ▲ +0.64 (+24.62%)
At close: Oct 23, 4:00 PM ET. Market closed.
$3.25 ▲ +0.01 (+0.39%)
After hours: Oct 23, 7:59 PM ET

Summary

Previous Close
$2.60
Open
$2.57
Day's Range
$2.57 – $3.26
52 Week Range
$0.84 – $4.31
Volume
13,485,716
Avg. Volume
3,435,333
Market Cap
$412.31M
Beta (5Y Monthly)
0.87
PE Ratio (TTM)
--
EPS (TTM)
-$0.45
Earnings Date
Oct 27, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$3.50

Profile: Nautilus Biotechnolgy, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
127
CEO
Sujal Patel

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples.

Earnings

Next report: Tue, Oct 27, 2026
EPS estimate -$0.14 · Revenue est. $206.25K
DateEst.Actual
Jul 28, 2026-$0.14-$0.11Beat
Apr 28, 2026-$0.15-$0.12Beat
Feb 26, 2026-$0.14-$0.11Beat
Oct 27, 2025-$0.15-$0.11Beat
Jul 31, 2025-$0.16-$0.12Beat
Apr 29, 2025-$0.14-$0.13Beat

Analyst view

Consensus price target
$3.50 ▲ +8.0%
Range $3.50 – $3.50
Rating: Buy
Buy 60% · Hold 20% · Sell 20%

Get free alerts on NAUT and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.